Comparable stake leader
ARMISTICE CAPITAL, LLC
SEC ownership of Glucotrack, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001506983.
Disclosed value leader
John Ballantyne
Comparable rows
14/23
Latest evidence
31 Mar 2026
- Public ticker
- GCTK on Nasdaq
- Parsed ownership sources
-
13D/G, 13F, and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
ARMISTICE CAPITAL, LLC
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
14 of 23
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
ARMISTICE CAPITAL, LLC
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
31 Mar 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001506983
- Issuer location
- Rutherford, NJ
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Glucotrack, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
John Ballantyne
Comparable rows
14/23
Latest evidence
31 Mar 2026
13D/G
13F
3/4/5
Lead comparable stake: 5%
9 rows are not safely comparable across share classes.
13D/G row: ARMISTICE CAPITAL, LLC
Showing 1-8 of 23 holder rows.
Quick read
ARMISTICE CAPITAL, LLC leads the comparable SEC ownership view at 5%.
14 of 23 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Comparable ownership
Top 5
ARMISTICE CAPITAL, LLC
5%
SABBY MANAGEMENT, LLC
4.9%
Ikarian Capital, LLC
4.5%
GEODE CAPITAL MANAGEMENT, LLC
2.3%
HRT FINANCIAL LP
2%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 23 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13D/G
|
5%
|
$89,861
102,115 shares
|
+$915 | 31 Mar 2026 |
| SABBY MANAGEMENT, LLC |
13D/G
|
4.9%
|
$241,352
647,055 shares
|
$0 | 31 Dec 2024 |
| Ikarian Capital, LLC |
13D/G
13F
Company
|
4.5%
|
$175,071
45,830 shares
|
$0 | 31 Dec 2025 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
2.3%
|
$30,550
47,001 shares
|
— | 31 Mar 2026 |
| HRT FINANCIAL LP |
13F
Company
|
2%
|
$26,000
40,631 shares
|
— | 31 Mar 2026 |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
Company
|
0.66%
|
$8,791
13,525 shares
|
— | 31 Mar 2026 |
| VANGUARD FIDUCIARY TRUST CO |
13F
Company
|
0.23%
|
$3,069
4,722 shares
|
— | 31 Mar 2026 |
| ALERUS FINANCIAL NA |
13F
Company
|
0.2%
|
$2,600
4,000 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 25 Jun 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-12 of 12 reporting-owner rows connected to Glucotrack, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
12
Largest Forms 3/4/5 holder
John Ballantyne
Net 12M change
$0
Latest report
22 May 2025
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| John Ballantyne | Director, 10%+ Owner | $85,179,227 | Mixed | 16 Aug 2024 | ||
| John A. Ballantyne Revocable Living Trust dated 08/01/2017 | 10%+ Owner | $85,051,321 | Mixed | 30 Jul 2024 | ||
| Drew Sycoff | Director, 10%+ Owner | $3,718,585 | Filing P/S | 01 Jul 2024 | ||
| Robert Fischell | Director | $63,804 | Mixed | 24 Aug 2021 | ||
| Andrew K. Balo | Director | $22,850 | Mixed | 26 Mar 2025 | ||
| Luis Malave | Director | $19,762 | Mixed | 25 Mar 2025 | ||
| Allen Danzig | Director | $18,960 | Mixed | 04 Oct 2022 | ||
| Erin Catherine Carter | Director | $10,460 | Mixed | 25 Mar 2025 | ||
| Paul Goode | Chief Executive Officer, Director | $1,650 | Mixed | 25 Mar 2025 | ||
| Brendel Victoria Carr | Director | Mixed | 22 May 2025 | |||
| Peter C. Wulff | Chief Financial Officer | Mixed | 28 Jan 2025 | |||
| James S. Cardwell | Chief Financial Officer | Mixed | 11 Oct 2023 |
Recent insider transactions for Glucotrack, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Andrew K. Balo | GCTK | Common Stock, par value $0.001 per share | Award | 37.7% | 1,285 | 4,692 | 03 Oct 2025 | Direct | ||
| Andrew K. Balo | GCTK | Stock option (right to buy) | Award | 4,055 | 4,055 | 03 Oct 2025 | Direct | |||
| Luis Malave | GCTK | Common Stock, par value $0.001 per share | Award | 12.9% | 463 | 4,058 | 03 Oct 2025 | Direct | ||
| Luis Malave | GCTK | Stock option (right to buy) | Award | 4,055 | 4,055 | 03 Oct 2025 | Direct | |||
| Erin Catherine Carter | GCTK | Common Stock, par value $0.001 per share | Award | 21.9% | 386 | 2,148 | 03 Oct 2025 | Direct | ||
| Erin Catherine Carter | GCTK | Stock option (right to buy) | Award | 4,055 | 4,055 | 03 Oct 2025 | Direct | |||
| Andrew K. Balo | GCTK | Common Stock, par value $0.001 per share | Award | 4442.7% | 3,332 | 3,407 | 11 Jul 2025 | Direct | ||
| Luis Malave | GCTK | Common Stock, par value $0.001 per share | Award | 50.1% | 1,200 | 3,595 | 11 Jul 2025 | Direct | ||
| Erin Catherine Carter | GCTK | Common Stock, par value $0.001 per share | Award | 131.2% | 1,000 | 1,762 | 11 Jul 2025 | Direct |
* marks a reported price that did not pass the local price check.